/Home/USA/Litigation: Securities: Plaintiffs in New York/Pomerantz LLP, US
Department profile
Pomerantz LLP, US
Department profile | Pomerantz LLP, US
Litigation: Securities: Plaintiffs

Chambers Review

Provided by Chambers

Litigation: Securities: Plaintiffs - New York

3
Band 3

What the Team is Known For

Pomerantz is a prominent player on the plaintiffs' side of securities litigation. It specializes in bringing class actions and shareholder derivative cases, as well as direct action litigations, against corporate issuers. The firm has achieved some of the largest settlements of the past few years on a nationwide level.

Work Highlights

  • Pomerantz achieved $97 million for investors in a case against Perrigo. Plaintiffs alleged that Perrigo concealed problems with its acquisition of Omega and anticompetitive pricing practices in its generic prescription drug business.

Strengths

Provided by Chambers

Pomerantz is able to explain the process to others who might not fully understand the legal language or judicial process. All of the team members are knowledgeable and have proven to be successful.

Litigation: Securities: Plaintiffs respondent
USA

Notable Practitioners

Provided by Chambers

Jeremy Lieberman
2
Jeremy Lieberman
2
Band 2
Jeremy Lieberman has had notable successes in significant class actions on behalf of institutional investors. He is also a strong choice for the representation of individual lead plaintiffs.
View Profile
3
Emma Gilmore
3
Band 3
Emma Gilmore has an impressive track record of success on the plaintiff side of major securities class actions, leading claims against large corporate issuers.
View Profile

Ranked Lawyers at
Pomerantz LLP, US

Provided by Chambers
Filter by
Band

New York

Litigation: Securities: Plaintiffs
Jeremy Lieberman
2
Jeremy Lieberman
2
Band 2
View Profile
3
Emma Gilmore
3
Band 3
View Profile